UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases.
As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology.
Company Details
- Employees
- 28
- Founded
- -
- Address
- 285 E Grand Ave, South San Francisco,california 94080,united States
- Phone
- 617-563-5800
- in****@****ogy.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- unitybiotechnology.com
- Keywords
- Retro Biosciences.
- HQ
- South San Francisco, California
Unity Biotechnology Questions
Unity Biotechnology's helpline number is 617-563-5800
Unity Biotechnology's website is unitybiotechnology.com
Unity Biotechnology's LinkedIn profile is https://www.linkedin.com/company/unity-biotechnology
Unity Biotechnology has
28 employees.
View email and phone details for 28
employees at Unity Biotechnology.
Unity Biotechnology's industry is
Biotechnology Research
Unity Biotechnology's top competitors are
Deep Longevity,
Insilico Medicine,
Calico Life Sciences,
Retro Biosciences,
Human Longevity, Inc.,
Agex Therapeutics, Inc.,
Bioage Labs,
Altos Labs,
Decode Age,
Juvenescence®.
Unity Biotechnology's support email address is info@unitybiotechnology.com
Unity Biotechnology's categories are Biotechnology Research
Unity Biotechnology's founding year is 2009
